Press Release 新聞稿

HKMA urges Citizens to get Influenza Vaccine





季節性流感疫苗接種計劃已於上月展開,醫學會傳染病顧問委員會聯席主席曾祈殷醫生表示,在新冠病毒疫情下,市民如同時感染新冠病毒和流感,併發症及死亡率均會大大增加。根據英格蘭公眾健康(Public Health England, PHE)的研究,同時感染新冠病毒及流感人士的死亡風險,比只感染新冠病毒的人高出一倍以上[1],因此接種新冠疫苗和流感疫苗同樣重要。



















5 November 2021

 Hong Kong Medical Association urges Citizens to get Influenza Vaccine


Entering the winter influenza season, the Hong Kong Medical Association (HKMA) held a press conference on 5 November to call on the public to get the seasonal influenza vaccine (SIV). The President of the HKMA, Dr. CHOI Kin, along with the HKMA Council Members and fellow medical students, demonstrated SIV vaccination on the spot to encourage the public to get vaccinated to prevent the double attack of influenza and COVID-19.


The seasonal influenza vaccination program was launched last month. Dr. TSANG Kay-yan, the co-chairman of the Advisory Committee on Communicable Diseases (ACCD) of the HKMA, stated that under the COVID-19 pandemic, if a person were co-infected with the COVID-19 and influenza, complications and the risk of death would increase enormously. According to the analysis from the Public Health England (PHE), the risk of death is more than doubled for people who catch flu on top of coronavirus, compared to coronavirus alone[2]. Therefore, vaccinations for the COVID-19 and influenza would be equally important.


Overseas governments have different guidelines for the interval period of the two vaccinations. The US Centers for Disease Control and Prevention (CDC) advises that flu vaccines and COVID-19 vaccines can be given at the same time. Australia suggests having an interval of 7 days, while the Hong Kong Centre for Health Protection (CHP) recommends 14 days apart. The HKMA agreed that the 14-days interval could be used to closely monitor the side effects of the two vaccines. In this regard, citizens should plan ahead and make appointments for both vaccinations accordingly.


Dr. CHAN Yee-shing, another co-chairman of the ACCD, reminded the general public that vaccination was still the best and a safe way for influenza prevention, and a person could still catch seasonal flu even if they wear a mask. Dr. CHAN mentioned that many people mistakenly believed that flu symptoms were mild, but serious complications could lead to death. According to the data provided by the Department of Health, 601 cases of influenza-associated admission to the Intensive Care Unit or death (356 deaths) were recorded during Year 18-19 influenza season. As the SIV takes two weeks to act, the public should get vaccinated as soon as possible.


In addition to vaccination, the public should also stay vigilant in personal hygiene for prevention, such as maintaining good indoor ventilation and washing hands after touching the mouth, nose and eyes. People with weaker immune systems, such as children and the elderly, should avoid crowded public places.  Last but not least, the public should consult professional advice from their family doctors on influenza vaccination.


The HKMA also received reports from private doctors regarding the limited supply of SIV this year and worried that the number of vaccines could not cope with the great demand before the winter influenza season. The HKMA President Dr. CHOI Kin urged the Government to maintain close communication with pharmaceutical companies to ensure SIV supply to Hong Kong would be sufficient.







Notes to editors: The Hong Kong Medical Association, founded in 1920, aims to bring together Hong Kong's government, institutional, university and private medical practitioners for an effective exchange of views and co-ordination of efforts.  The foremost objective of the Association is to safeguard and promote public health.  The Association speaks collectively for its members and aims to keep its members abreast of medical ethics, issues and advances around the world.  In fulfilling these goals, the association hopes to better serve the people of Hong Kong.


    查詢   :袁巧蓮女士                                        電話   :2527 8941 

    網址                                電郵